Very interesting article about Alzheimer’s

The November 9, 2026 issue of The New Yorker magazine has a really interesting article on Alzheimer’s research. It is by Manvir Singh and is entitled “The Alzheimer’s Wars.” I would post the link but it would be paywalled. If you are interested, the best resource would be a library. If you are wondering about infusions, you will learn a lot.

Comments

  • Damiross
    Damiross Member Posts: 87
    25 Insightfuls Reactions 25 Likes 25 Care Reactions 10 Comments
    Member
    edited November 10

    I came across this article by the sam author date Novembe 2, 2026.

    https://www.newyorker.com/magazine/2026/11/09/did-the-world-just-gain-hundreds-of-millions-of-alzheimers-patients

    Gemini AI summary:
    In The New Yorker article "Did the World Just Gain Hundreds of Millions of Alzheimer’s Patients?" (by Manvir Singh), the author examines how recent shifts in how Alzheimer's is defined and tested have the potential to suddenly reclassify hundreds of millions of healthy people as patients.

    The core themes and arguments of the article include:

    1. The Redefinition of Alzheimer’s (Biomarkers vs. Symptoms)

    • Historically, Alzheimer's disease was diagnosed primarily based on clinical symptoms—such as cognitive decline, memory loss, and behavioral changes.
    • However, updated diagnostic criteria and guidelines (such as those from the Alzheimer's Association) have shifted the focus toward biology. Using specialized brain scans, spinal taps, and newly developed, highly accurate blood tests, doctors can now detect underlying biological markers of the disease—specifically beta-amyloid plaques—years or even decades before any memory problems appear.

    2. Why "Hundreds of Millions" of New Patients?

    • Roughly a quarter of all adults over sixty-five who show zero cognitive symptoms actually carry brain amyloid accumulations.
    • Applying this biological definition worldwide drastically inflates patient numbers. Millions of individuals who feel completely healthy, function independently, and might never develop full-blown dementia during their lifetimes could now technically receive an Alzheimer's diagnosis.

    3. The Controversy Over New Drugs

    • The rise in testing coincides with the FDA approval of monoclonal antibody treatments (like lecanemab and donanemab) designed to clear amyloid from the brain.
    • While these drugs can slow cognitive decline in early symptomatic patients, their overall clinical benefit is modest, and they carry significant health risks, such as brain swelling and microhemorrhages. Furthermore, it remains unproven whether treating asymptomatic people purely because of a biomarker blood test will actually stop them from ever developing dementia.

    4. The Psychological and Social Toll

    • Giving someone a diagnostic label for a progressive, feared disease when they have no symptoms can trigger intense anxiety, change how they view their health, and alter major life choices.
    • The article raises critical questions about the intersection of medical science, mass screening, and the pharmaceutical industry—cautioning that turning biological indicators into formal diseases risks pathologizing normal aging without guaranteeing a better quality of life.
  • Maru
    Maru Member Posts: 593
    500 Likes 500 Care Reactions 250 Insightfuls Reactions 500 Comments
    Member

    No surprise there…big pharma makes a lot of people very rich. They do the research, then show their research to doctors to get them to prescribe their products.

  • beachwalker5
    beachwalker5 Member Posts: 41
    25 Insightfuls Reactions 25 Likes 10 Comments 25 Care Reactions
    Member
    edited November 11

    My understanding is that there are lots of us geezers who have beta amyloid plaques but show no symptoms of memory loss or cognitive impairment. Until there is a blood test that measures memory loss or cognitive impairment, how can a neurologist diagnose AD solely based on biological data????

    This subject reminds me of PSA blood testing for prostate cancer. No urologist would ever diagnose a man with prostate cancer based solely on a high PSA blood test, but a high PSA could lead to an MRI and biopsy which are the gold standard for a cancer diagnosis.

  • notequipped
    notequipped Member Posts: 186
    100 Likes 100 Comments 25 Care Reactions 25 Insightfuls Reactions
    Member

    I don’t think that anyone solely applies the biological definition when diagnosing AD. I think that there are still more unknowns than answers.

Commonly Used Abbreviations


DH = Dear Husband
DW= Dear Wife, Darling Wife
LO = Loved One
ES = Early Stage
EO = Early Onset
FTD = Frontotemporal Dementia
VD = Vascular Dementia
MC = Memory Care
AL = Assisted Living
POA = Power of Attorney
Read more